Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 1
2004 3
2005 2
2006 2
2007 1
2008 2
2009 1
2010 2
2011 1
2012 2
2013 3
2014 3
2015 3
2016 2
2017 6
2018 2
2019 6
2020 4
2021 2
2022 2
2023 3
2024 5
2025 4
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Correction: Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism.
Fumarola C, Cretella D, Monica S, Bonelli MA, Alfieri R, Caffarra C, Quaini F, Madeddu D, Falco A, Cavazzoni A, Digiacomo G, Mazzaschi G, Vivo V, Barocelli E, Tiseo M, Petronini PG, Ardizzoni A. Fumarola C, et al. Among authors: bonelli ma. Oncotarget. 2026 Mar 27;17(1):76-77. doi: 10.18632/oncotarget.28844. Print 2026 Jan 6. Oncotarget. 2026. PMID: 41954999 Free PMC article. No abstract available.
Correction: Cavazzoni et al. Pemetrexed Enhances Membrane PD-L1 Expression and Potentiates T Cell-Mediated Cytotoxicity by Anti-PD-L1 Antibody Therapy in Non-Small-Cell Lung Cancer. Cancers 2020, 12, 666.
Cavazzoni A, Digiacomo G, Alfieri R, La Monica S, Fumarola C, Galetti M, Bonelli M, Cretella D, Barili V, Zecca A, Giovannetti E, Fiorentino M, Tiseo M, Petronini PG, Ardizzoni A. Cavazzoni A, et al. Among authors: bonelli m. Cancers (Basel). 2025 Apr 8;17(8):1254. doi: 10.3390/cancers17081254. Cancers (Basel). 2025. PMID: 40282559 Free PMC article.
Correction: The anti-tumor efficacy of CDK4/6 Inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells.
Cretella D, Ravelli A, Fumarola C, La Monica S, Digiacomo G, Cavazzoni A, Alfieri R, Biondi A, Generali D, Bonelli M, Petronini PG. Cretella D, et al. Among authors: bonelli m. J Exp Clin Cancer Res. 2025 Apr 16;44(1):122. doi: 10.1186/s13046-025-03383-x. J Exp Clin Cancer Res. 2025. PMID: 40234850 Free PMC article. No abstract available.
Corrigendum to "Mesenchymal stromal cells loaded with Paclitaxel (PacliMES) a potential new therapeutic approach on mesothelioma" [Biochem. Pharmacol. 214 (2023) 115678].
Coccè V, Bonelli M, Monica S, Alfieri R, Doneda L, Martegani E, Alessandri G, Lagrasta CA, Giannì A, Sordi V, Petrella F, Roncoroni L, Paino F, Pessina A. Coccè V, et al. Among authors: bonelli m. Biochem Pharmacol. 2025 Jan;231:116653. doi: 10.1016/j.bcp.2024.116653. Epub 2024 Nov 28. Biochem Pharmacol. 2025. PMID: 39612648 No abstract available.
Immunomodulatory effects of antiangiogenic tyrosine kinase inhibitors in renal cell carcinoma models: Impact on following anti-PD-1 treatments.
Fumarola C, La Monica S, Bonelli M, Zoppi S, Alfieri R, Galetti M, Gnetti L, Campanini N, Pozzi G, Cavazzoni A, Mazzaschi G, Silini EM, Buti S, Petronini PG. Fumarola C, et al. Among authors: bonelli m. Biochem Pharmacol. 2024 Aug;226:116397. doi: 10.1016/j.bcp.2024.116397. Epub 2024 Jun 27. Biochem Pharmacol. 2024. PMID: 38944394 Free article.
Targeting metabolic adaptive responses induced by glucose starvation inhibits cell proliferation and enhances cell death in osimertinib-resistant non-small cell lung cancer (NSCLC) cell lines.
Eltayeb K, Alfieri R, Fumarola C, Bonelli M, Galetti M, Cavazzoni A, Digiacomo G, Galvani F, Vacondio F, Lodola A, Mor M, Minari R, Tiseo M, La Monica S, Giorgio Petronini P. Eltayeb K, et al. Among authors: bonelli m. Biochem Pharmacol. 2024 Oct;228:116161. doi: 10.1016/j.bcp.2024.116161. Epub 2024 Mar 24. Biochem Pharmacol. 2024. PMID: 38522556 Free article.
Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models.
La Monica S, Vacondio F, Eltayeb K, Lodola A, Volta F, Viglioli M, Ferlenghi F, Galvani F, Galetti M, Bonelli M, Fumarola C, Cavazzoni A, Flammini L, Verzè M, Minari R, Petronini PG, Tiseo M, Mor M, Alfieri R. La Monica S, et al. Among authors: bonelli m. Sci Rep. 2024 Mar 18;14(1):6491. doi: 10.1038/s41598-024-57028-8. Sci Rep. 2024. PMID: 38499619 Free PMC article.
62 results